# Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction

> **NCT02069106** · PHASE4 · WITHDRAWN · sponsor: **Nordic Pharma, USA**

## Conditions studied

- Mixed Hyperlipoproteinemia

## Interventions

- **DIETARY_SUPPLEMENT:** Pro-Omega LDL
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02069106
- **Lead sponsor:** Nordic Pharma, USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-02
- **Primary completion:** 2014-05
- **Final completion:** 2014-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02069106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02069106, "Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02069106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*